HARBOR INVESTMENT ADVISORY, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1468792
LUTHERVILLE, MD
Position in NBIX
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$111,236
+$109,719 QoQ
Shares Held
660
+5900.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#621
of 768 holders
Holding Since
Mar 2024
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HARBOR INVESTMENT ADVISORY, LLC holds $593,119 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
614 | $332,683 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
660 | $111,236 | |
| 3 | ALKS |
Alkermes plc.
|
1,556 | $81,526 | |
| 4 | ZTS |
Zoetis Inc.
|
716 | $51,451 | |
| 5 | VTRS |
Viatris Inc
|
960 | $15,244 | |
| 6 | HLN |
Haleon plc
|
100 | $933 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1 | $33 | |
| 8 | CRON |
Cronos Group Inc.
|
5 | $13 |
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,236 | 660 | Shares | Sole | 2026-07-07 | |
| 2024-03-31 | $1,517 | 11 | Shares | Sole | 2024-04-12 | |
| No filing history on record for this holder in this stock. | ||||||